Medicare spending analysis for Gynecological Oncology providers
Gynecological Oncology accounts for $461.6M in Medicare payments across 7.6K providers.
The specialty's average markup of 4.1x is above the overall Medicare average of 3.77x.
AI-generated analysis based on Medicare payment data.
| Year | Payments | Services | Providers | YoY Change |
|---|---|---|---|---|
| 2016 | $59.1M | 3.3M | 923 | — |
| 2017 | $60.9M | 3.3M | 932 | +3.2% |
| 2018 | $59.0M | 3.1M | 940 | -3.2% |
| 2019 | $61.1M | 3.4M | 947 | +3.5% |
| 2020 | $58.0M | 3.5M | 943 | -5.0% |
| 2021 | $61.1M | 3.3M | 967 | +5.3% |
| 2022 | $51.6M | 2.5M | 976 | -15.6% |
| 2023 | $50.8M | 2.4M | 981 | -1.4% |
| # | Provider | State | Payments | Services | Avg/Service |
|---|---|---|---|---|---|
| 1 | Mark Reed | TN | $2.3M | 212.9K | $10.60 |
| 2 | William Merritt | SC | $1.1M | 135.7K | $8.41 |
| 3 | Randal West | VA | $1.1M | 127.1K | $8.77 |
| 4 | Michael Ulm | TN | $1.1M | 76.7K | $14.41 |
| 5 | Todd Tillmanns | TN | $1.1M | 72.1K | $15.30 |
| 6 | Sudarshan Sharma | IL | $1.1M | 54.4K | $19.58 |
| 7 | Michael Mccollum | VA | $908.4K | 77.8K | $11.67 |
| 8 | Noelle Cloven | TX | $807.0K | 35.7K | $22.59 |
| 9 | Robert Squatrito | VA | $791.4K | 87.3K | $9.06 |
| 10 | Edward Tanner | DC | $786.3K | 37.1K | $21.20 |
| 11 | Carrie Mcilwain | IL | $760.7K | 36.8K | $20.67 |
| 12 | Nora Maczura | IL | $716.3K | 63.1K | $11.34 |
| 13 | Linda Smiley | TN | $633.8K | 46.5K | $13.64 |
| 14 | Michael Gold | OK | $615.6K | 70.0K | $8.80 |
| 15 | Dwight Im | MD | $540.8K | 2.7K | $204.01 |
| 16 | Eric Thomas | OK | $536.3K | 50.3K | $10.67 |
| 17 | Nikki Neubauer | IL | $497.2K | 20.6K | $24.15 |
| 18 | James Williams | SC | $460.9K | 90.4K | $5.10 |
| 19 | Fernando Recio | FL | $456.4K | 26.2K | $17.44 |
| 20 | Alfred Jenkins | OK | $421.1K | 27.1K | $15.54 |
| 21 | Alfred Guirguis | IL | $418.1K | 10.1K | $41.27 |
| 22 | Ketura Wisner | NM | $410.9K | 30.7K | $13.38 |
| 23 | Daron Street | OK | $406.0K | 51.6K | $7.87 |
| 24 | Michael Dobelbower | AL | $401.5K | 2.0K | $202.66 |
| 25 | Ramin Mirhashemi | CA | $383.7K | 41.5K | $9.26 |
| Code | Description | Payments | Services | Avg/Service |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | $8.4M | 194.6K | $43.08 |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | $7.3M | 85.7K | $85.22 |
| 58571 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | $5.7M | 8.2K | $695.32 |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | $4.4M | 36.4K | $121.57 |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | $3.5M | 61.2K | $57.07 |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | $3.1M | 19.9K | $157.17 |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | $1.5M | 12.6K | $118.28 |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | $1.1M | 11.5K | $99.10 |
| J9035 | Injection, bevacizumab, 10 mg | $994.0K | 17.6K | $56.61 |
| Q5107 | Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | $795.4K | 34.9K | $22.77 |
| J9299 | Injection, nivolumab, 1 mg | $682.9K | 28.9K | $23.66 |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | $562.4K | 6.7K | $83.69 |
| J0897 | Injection, denosumab, 1 mg | $549.2K | 30.0K | $18.31 |
| Q5126 | Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg | $519.8K | 10.1K | $51.45 |
| 38570 | Biopsy and removal of lymph nodes of abdominal cavity using an endoscope | $450.3K | 2.2K | $207.99 |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | $449.0K | 418 | $1.1K |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | $446.2K | 7.1K | $62.55 |
| 38900 | Imaging of lymph nodes during surgery | $443.6K | 3.1K | $141.72 |
| J1449 | Injection, eflapegrastim-xnst, 0.1 mg | $401.1K | 15.4K | $25.97 |
| Q5118 | Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg | $392.8K | 16.4K | $23.94 |
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.